Randomized Clinical Trial to Study the Effect of Extended Release Niacin on Endothelial Function, Oxidative Stress and Endothelial Progenitor Cells in Patients With the Metabolic Syndrome

Trial Profile

Randomized Clinical Trial to Study the Effect of Extended Release Niacin on Endothelial Function, Oxidative Stress and Endothelial Progenitor Cells in Patients With the Metabolic Syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2009

At a glance

  • Drugs Niacin (Primary)
  • Indications Metabolic syndrome
  • Focus Pharmacodynamics
  • Acronyms High-Ennd
  • Most Recent Events

    • 05 May 2008 Actual patient number from clinicaltrials.gov record is 32.
    • 08 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top